Gain Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Gain Therapeutics's balance sheet done over the years? Its assets were worth $18,609,331 last year, which is less than in the previous period. 32% of Gain Therapeuticsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $6,031,107, which means an increase by 16% compared compared to last year.

Debt to Assets

Gain Therapeutics, Inc. (NASDAQ:GANX): Debt to assets
2019 660286 1.11M 168.13%
2020 9604358 3.40M 35.43%
2021 38985071 4.16M 10.69%
2022 24099387 5.21M 21.66%
2023 18609331 6.03M 32.41%

GANX Balance Sheet (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
11.79M7.31M36.88M7.49M303.32K
Short term investments
4.99M12.82M000
Net receivables
242.57K103.87K113.58K66.56K44.91K
Inventory
0001.35M31.47K
Other current assets
741.63K848.85K727.78K70.98K49.81K
Total current assets
17.77M21.09M37.72M8.98M429.52K
Non-current assets:
Property, Plant and Equipment
585.17K804.31K1.00M552.71K219.34K
Goodwill
00000
Intangible assets
193.37K213.96K202.60K00
Long term investments
01.94M31.27K010.38K
Other non-current assets
51.91K48.32K53.39K63.81K1.03K
Total non-current assets
830.46K3.00M1.26M616.53K230.76K
Total assets
18.60M24.09M38.98M9.60M660.28K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
1.12M55.18K266.50K239.48K368.79K
Short term debt
348.49K337.21K322.96K145.38K102.10K
Total current liabilities
4.94M4.12M2.55M2.11M879.05K
Non-current liabilities:
Long term debt
678.90K937.04K1.28M1.11M98.84K
Deferred tax
00000
Other non-current liabilities
307.45K157.58K329.45K171.55K132.24K
Total non-current liabilities
1.08M1.09M1.61M1.28M231.09K
Total liabilities
6.03M5.21M4.16M3.40M1.11M
Data sourceData sourceData source